毛细支气管炎患儿应用宣肺化痰散瘀汤联合乙酰半胱氨酸治疗的效果及安全性分析
DOI:
作者:
作者单位:

河南中医药大学第五临床医学院(郑州人民医院)

作者简介:

通讯作者:

中图分类号:

基金项目:


Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 观察宣肺化痰散瘀汤联合乙酰半胱氨酸治疗毛细支气管炎患儿的治疗效果及其安全性。方法 选取2021年9月~2023年9月期间于本院诊治的94例毛细支气管炎患儿作为研究对象。随机将患儿分为对照组和观察组,每组各47例。对照组予以乙酰半胱氨酸治疗;观察组予以宣肺化痰散瘀汤联合乙酰半胱氨酸治疗。分析比较两组的临床疗效、临床症状消失时间及动脉血气分析指标[动脉血二氧化碳分压(PaCO2)、动脉血酸碱度(pH)、血氧饱和度(SpO2)]、炎症反应[嗜酸性粒细胞阳离子蛋白(ECP)、嗜酸性粒细胞(EOS)、白细胞介素-4(IL-4)、γ-干扰素(IFN-γ)]、免疫功能(CD3+、CD4+、CD8+)以及不良反应发生。结果 观察组的治疗总有效率显著高于对照组(P<0.05)。观察组的气喘、咳嗽、喘鸣音、肺啰音各项临床症状消失时间均较对照组显著缩短(P<0.05)。治疗后,两组的PaCO2降低,pH、SpO2升高;且观察组治疗后的PaCO2显著降低,pH、SpO2均显著升高(P<0.05)。与治疗前比较,两组治疗后血清ECP、EOS、IL-4、IFN-γ水平降低,且观察组的血清ECP、EOS、IL-4、IFN-γ水平均显著低于对照组(P<0.05)。与治疗前比较,两组治疗后的CD3+、CD4+升高,CD8+降低;且观察组治疗后的CD3+、CD4+显著升高,CD8+显著降低(P<0.05)。两组的不良反应均无显著差异(P>0.05)。结论 宣肺化痰散瘀汤联合乙酰半胱氨酸治疗毛细支气管炎患儿,能提高疗效,促进病情恢复,改善动脉血气,减轻机体炎症状态,提高机体免疫功能,且具有一定安全性。

    Abstract:

    Objective To observe the efficacy and safety of Xuanfei Huatan Sanyu Decoction combined with acetylcysteine in the treatment of children with bronchiolitis. Methods 94 children with bronchiolitis diagnosed and treated in our hospital from September 2021 to September 2023 were selected as the study objects. The children were randomly divided into control group and observation group, with 47 cases in each group. The control group was treated with acetylcysteine. Observation group was treated with Xuanfei Huatan Sanyu Decoction combined with acetylcysteine. The clinical efficacy, duration of clinical symptoms and arterial blood gas analysis indexes [PaCO2, pH, SpO2], inflammatory response [ECP, EOS, IL-4, IFN-γ], immune function (CD3+, CD4+, CD8+), and the occurrence of adverse reactions of the two groups were analyzed and compared. Results The total effective rate of observation group was significantly higher than that of control group (P < 0.05). The disappearance time of asthma, cough, wheezing sound and pulmonary rales in the observation group was significantly shorter than that in the control group (P < 0.05). After treatment, PaCO2 decreased, pH and SpO2 increased in both groups. After treatment, PaCO2 was significantly decreased, pH and SpO2 were significantly increased in the observation group (P < 0.05). Compared with before treatment, the serum ECP, EOS, IL-4 and IFN-γ levels of the two groups were decreased after treatment, and the serum ECP, EOS, IL-4 and IFN-γ levels of the observation group were significantly lower than those of the control group (P < 0.05). Compared with before treatment, CD3+ and CD4+ increased and CD8+ decreased in both groups after treatment. After treatment, CD3+ and CD4+ were significantly increased, while CD8+ was significantly decreased in observation group (P < 0.05). There were no significant differences in adverse reactions between the two groups (P > 0.05). Conclusion Xuanfei Huatan Sanyu Decoction combined with acetylcysteine in the treatment of children with bronchiolitis can improve the curative effect, promote the recovery of the disease, improve the arterial blood gas, reduce the inflammatory state of the body, improve the immune function, and has certain safety.

    参考文献
    相似文献
    引证文献
引用本文

宫廷.毛细支气管炎患儿应用宣肺化痰散瘀汤联合乙酰半胱氨酸治疗的效果及安全性分析[J].四川生理科学杂志,2025,47(8):

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-09-12
  • 最后修改日期:2024-12-03
  • 录用日期:2024-12-28
  • 在线发布日期: 2025-08-31
  • 出版日期: